Hepatocellular carcinoma and African iron overload

Gut

Volumn 37, Issue 5, 1995, Pages 727-730

  Gangaidzo, I T ^a   Gordeuk, V R ^b  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Epidemiology; Hepatocellular carcinoma; Iron

Indexed keywords

ARTICLE; CONTROLLED STUDY; HEMOCHROMATOSIS; HEPATITIS B; HUMAN; IRON OVERLOAD; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0028894852     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.37.5.727     Document Type: Article

References (53)

1. Rustigi VK. Epidermiology of hepatocellular carcinoma. Gastroenterol Clin North Am 1987; 16: 545-51.
2. Van der Merwe. Primary liver cancer in South Africa. A review. Gastroenterology Forum 1990; 1: 7-16.
3. Kew MC, Desmyter J, Bradburne AF, Macnab GM. Hepatitis B virus infection in Southern African Blacks with hepatocellular carcinoma. J Natl Cancer Inst 1979; 62: 517-20.
4. Peers F, Bosch X, Kaldor J, Linsell CA, Pluijmen M. Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. Int J Cancer 1987; 39: 545-53.
5. Lutwick LI. Relationship between aflatoxin, hepatitis B virus, and hepatocellular carcinoma. Lancet 1979; i: 755-7.
6. Mohamed A, Kew MC, Groeneveld HT. Alcohol consumption as a risk factor for hepatocellular carcinoma in urban South African Blacks. Int J Cancer 1992; 51: 537-41.
7. Kew MC. Hepatocellular carcinoma with and without cirrhosis: a comparison in southern African blacks. Gastroenterology 1989; 97: 136-9.
8. Beasley RP, Hwang L-Y, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus - A prospective study of 22 707 men in Taiwan. Lancet 1981; 2: 1129-33.
9. Leevy CM, Gellene R, Ning M. Primary liver cancer in cirrhosis of the alcoholic. Ann NY Acad Sci 1964; 114: 1026-40.
10. Bothwell TH, Bradlow BA. Siderosis in the Bantu. A combined histopathological and chemical study. Arch Pathol 1960; 70: 279-92.
11. Isaacson C, Seftel HC, Keeley KJ, Bothwell TH. Siderosis in the Bantu: the relationship between iron overload and cirrhosis. J Lab Clin Med 1961; 58: 845-53.
12. Paterson AC, Kew MC, Herman AAB, Becker PJ, Hodkinson J, Isaacson C. Liver morphology in Southern African Blacks with hepatocellular carcinoma: a study within an urban environment. Hepatology 1985; 5: 72-8.
13. Dusheiko G. Hepatocellular carcinoma: molecular biology, etiology and animal model. Gastroenterol Clin North Am 1987; 16: 575-89.
14. Barrin F, Perrin J, Chortard J, Denis F, N'Doye R, Diop Mar I, et al. Cross-sectional and longitudinal epidemiology of hepatitis B in Senegal. Prog Med Virol 1981; 27: 148-62.
15. Kew MC, Rossouw E, Hodgkinson HJ. Hepatitis B virus status of southern African Blacks with hepatocellular carcinoma: comparison between rural and urban patients. Hepatology 1983; 3: 65-8.
16. Jaskiewicz K, Stephen A, Banach L. Hepatocellular carcinoma in a rural population at risk. Anticancer Res 1991; 11: 2187-90.
17. Ryder RW, Whittle HC, Sanneth AB, Aldukiewicz AB, Tulloch S, Yvonnet B. Persistent hepatitis B virus infection and hepatoma in the Gambia, West Africa. A case-controlled study of 140 adults and their 603 family contacts. Am J Epidemiol 1992; 136: 1122-31.
18. Larouze B, Blumberg BS, London WT, Lustbader ED, Sankale M, Payet M. Forecasting the development of primary hepatocellular carcinoma by the use of risk factors: studies in West Africa. J Natl Cancer Inst 1977; 58: 1557-61.
19. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11, 065 presumably healthy blood donors. N Engl J Med 1988; 318: 1355-62.
20. Nierderau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G, et al. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemocromatosis. N Engl J Med 1985; 313: 1256-62.
21. Loeb LA, James EA, Waltersdorph AM, Klebanoff SJ. Mutagenesis by the autoxidation of iron with isolated DNA. Proc Natl Acad Sci USA 1988; 85: 3918-22.
22. Hann HWL, Stahlhut MW, Hann L. Effect of iron and desferoxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines. Hepatology 1990; 11: 566-9.
23. Bothwell TH, Charlton RW, Cook JD, Finch CA. Iron metabolism in man. Oxford: Blackwell Scientific, 1979.
24. Fellows IW, Stewart M, Jeffcoate WJ, Smith PG, Toghill PJ. Hepatocellular carcinoma in primary haemachromatosis in the absence of cirrhosis. Gut 1988; 29: 1603-6.
25. Blumberg RS, Chopra S, Ibrahim R, Crawford J, Farraye FA, Zeldis JB, et al. Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirhosis. Gastroenterology 1988; 95: 1399-402.
26. Gordeuk VR, Boyd RD, Brittenham GM. Dietary iron overload persists in rural sub-Saharan Africa. Lancet 1986; i: 1310-3.
27. Gordeuk VR. Hereditary and nutritional iron overload. Baillieres Clin Haematol 1992; 5: 169-86.
28. Strachan AS. Haemosiderosis and haemochromatosis in South African Natives with a comment on Etiology of haemochromatosis [thesis]. Glasgow: University of Glasgow, 1929.
29. Bothwell TH, Seftel H, Jacobs P. Iron overload in Bantu subjects. Studies on the availability of iron in Bantu beer. Am J Clin Nutr 1964; 14: 47-51.
30. Olweny C. Cancer. In: Parry EO, ed. Principles of medicine in Africa. 2nd ed. Oxford: Oxford University Press, 1984: 973-93.
31. Haddock DRW. Bantu siderosis in Tanzania. E Afr Med J 1965; 42: 67-71.
32. Owor R. Haemosiderosis in Uganda: Autopsy study. East Afr Med J 1974; 51: 388-91.
33. Dodu SRA. Diabetes and haemosiderosis - haemochromatosis - in Ghana. Trans R Soc Trop Med Hyg 1958; 52: 425-31.
34. Isah HS, Fleming AF. Anaemia and iron status of symptom-free adult males in northern Nigeria. Ann Trop Med Parasitol 1985; 79: 479-84.
35. Gordeuk V, Mukiibi J, Hasstedt SJ, Samowitz. W, Edwards CQ, West G, et al. Iron overload in Africa - interaction between a gene and dietary iron content. N Engl J Med 1992; 326: 95-100.
36. Higginson J. The geographic pathology of primary liver cancer. Cancer Res 1963; 23: 1624-33.
37. Higginson J. Primary carcinoma of the liver in Africa. Br J Cancer 1956; 10: 609-22.
38. Higginson J. Pathogenesis of liver cancer in the Johannesburg area (S Africa). Acta-Unio Internationalis Contra Cancrum 1957; 13: 590-8.
39. Higginson J, Gerritsen T, Walker ARP. Siderosis in the Bantu of Southern Africa. Am J Pathol 1953; 29: 779-815.
40. Higginson J, de Meillon B. Schistosoma haematobium infestation and hepatic disease in man. Arch Pathol 1955; 60: 341-6.
41. Butt EM, Higginson J. Trace element pattern in liver disease and liver carcinoma. Acta-Unio Internationalis Contra Cancrum 1957; 13: 599-601.
42. Hershko C. Storage iron regulation. Prog Haematol 1977; 10: 105-48.
43. Whittaker P, Skikne BS, Covell AM, Flowers C, Cooke A, Lynch SR, et al. Duodenal iron proteins in idiopathic hemochromatosis. J Clin Invest 1989; 83: 261-7.
44. Bothwell TH, Abrahams C, Bradlow BA, Charlton RW. Idiopathic and Bantu hemochromatosis. Arch Pathol 1965; 79: 163-8.
45. Brink B, Disler P, Lynch S, Jacobs P, Charlton R, Bothwell T. Patterns of iron storage in dietary iron overload and idiopathic hemochromatosis. J Lab Clin Med 1976; 88: 725-31.
46. Friedman BM, Baynes RD, Bothwell TH, Gordeuk VR, Macfarlane BJ, Camparelli RD, et al. Dietary iron overload in southern African rural blacks. S Afr Med J 1990; 78: 301-5.
47. Bloom P, Gordeuk VR, Barry M, Phiri B, Paterson A, MacPhail AP. Increased transferrin saturation in an African with iron overload but with no cirrhosis. Blood 1993; 82: 432a.
48. Gutteridge JM, Rowley DA, Griffiths E, Halliwell B. Low molecular weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clin Sci 1985; 68: 463-7.
49. Hershko C, Graham G, Bates GW, Rachmilewitz EA. Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Br J Haematol 1978; 40: 255-63.
50. Gordeuk VR, McLaren GD, Samowitz Wade. Etiologies, consequences and treatment of iron overload. Crit Rev Clin Lab Sci 1994; 31: 89-133.
51. Halliwell B, Gutteridge JMC, Cross CE. Free radicals, antioxidants, and human disease. J Lab Clin Med 1992; 119: 598-620.
52. Fargion S, Piperno A, Fracanzani AL, Cappellini MD, Romano R, Fiorelli G. Iron in the pathogenesis of hepatocellular carcinoma. Ital J Gastroenterol 1991; 23: 584-8.
53. Schwarz, Korba. Desferioxamine (DF) inhibits hepatitis B virus (HBV) virion production by HEP G2 (2.2.15) cells. Hepatology 1990; 12: 972.